| SCHEDULE OF SEGMENTAL FINANCIAL INFORMATION |
The
following table presents key financial information for the Company’s 1single reportable segment for the years ended December 31,
2025 and 2024:
SCHEDULE
OF SEGMENTAL FINANCIAL INFORMATION
| | |
Year Ended
December 31, 2025 | | |
Year Ended
December 31, 2024 | |
| Revenues | |
$ | 431,609 | | |
$ | 136,643 | |
| Cost of sales | |
| 100,127 | | |
| 130,638 | |
| Gross profit | |
$ | 331,482 | | |
$ | 6,005 | |
| Research and development expense | |
| 1,956,270 | | |
| 2,236,690 | |
| Total operating expenses (excl. impairment) | |
| 16,576,274 | | |
| 14,707,020 | |
| Impairment loss | |
| 26,346,050 | | |
| — | |
| Total operating expenses | |
$ | 42,922,324 | | |
$ | 14,707,020 | |
| Operating loss | |
| (42,590,842 | ) | |
| (14,701,015 | ) |
| Net loss from continuing operations, net of tax | |
$ | (41,512,264 | ) | |
$ | (18,244,480 | ) |
| Total assets (at period end) | |
$ | 84,178,330 | | |
$ | 104,853,805 | |
|